The trading price of Corcept Therapeutics Inc (NASDAQ:CORT) floating lower at last check on Monday, April 22, closing at $22.32, -2.77% lower than its previous close.
The company’s P/E ratio in the trailing 12-month period was 23.54. In examining the 52-week price action we see that the stock hit a 52-week high of $34.28 and a 52-week low of $20.87. Over the past month, the stock has lost -9.84% in value.
Corcept Therapeutics Inc, whose market valuation is $2.31 billion at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by $0.22 per share this quarter, however they have predicted annual earnings per share of $1.02 for 2024 and $1.28 for 2025. It means analysts are expecting annual earnings per share growth of 8.50% this year and 25.50% next year.
Analysts have forecast the company to bring in revenue of $141.2 million for the current quarter, with the likely lows of $136 million and highs of $145.84 million. The average estimate suggests sales will likely up by 33.60% this quarter compared to what was recorded in the comparable quarter last year. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $610.64 million. The company’s revenue is forecast to grow by 26.60% over what it did in 2024.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Corcept Therapeutics Inc no upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest CORT has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that CORT’s price is currently -8.43% off the SMA20 and -6.54% off the SMA50. The RSI metric on the 14-day chart is currently showing 37.62, and weekly volatility stands at 3.28%. When measured over the past 30 days, the indicator reaches 3.37%. Corcept Therapeutics Inc (NASDAQ:CORT)’s beta value is currently sitting at 0.51, while the Average True Range indicator is currently displaying 1.00.
To see how Corcept Therapeutics Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: CORT stock’s performance was -2.77% at last check in today’s session, and 0.07% in the past year. Corcept Therapeutics Inc has a P/E ratio of 23.54.
An evaluation of the daily trading volume of Corcept Therapeutics Inc (NASDAQ:CORT) indicates that the 3-month average is 1.21 million.
Currently, records show that 103.41 million of the company’s shares remain outstanding. The insiders hold 13.84% of outstanding shares, whereas institutions hold 82.35%. However, since the stock’s price has seen -31.30% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
